Estroact 60 Mg Tablet (Raloxifene)
Required
About Estroact 60 Mg Tablet (Raloxifene)
Medicine information
- Active ingredient
- Raloxifene hydrochloride
- Indication
- Treatment and prevention of osteoporosis in postmenopausal women; reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk of invasive breast cancer. Raloxifene is not indicated to treat existing invasive breast cancer, prevent its recurrence, or reduce the risk of noninvasive breast cancer.
- Strength
- 60 mg
- Dosage form
- Tablet
- Route
- Oral
Medicine overview
Estroact 60 Mg Tablet contains raloxifene, a selective estrogen receptor modulator (SERM). Raloxifene has estrogen-like effects in some tissues while blocking estrogen activity in others. It is used in postmenopausal women to prevent or treat osteoporosis and, in appropriate women, to reduce the risk of invasive breast cancer. The exact manufacturer and pack configuration of the Estroact-branded product could not be reliably verified from authoritative product-specific sources.
What it is used for
Raloxifene is used to prevent and treat osteoporosis after menopause by helping reduce bone loss and improve bone mineral density. It is also approved to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are considered at high risk for invasive breast cancer. It does not treat established breast cancer and is not approved to prevent breast cancer recurrence.
How it works
Raloxifene is a selective estrogen receptor modulator. It binds to estrogen receptors and can either activate or block estrogen-related effects depending on the tissue. In bone, it acts in an estrogen-like way, reducing bone breakdown and turnover and helping maintain or increase bone mineral density. In breast tissue, it blocks certain estrogen effects, which explains its role in reducing the risk of some invasive breast cancers in postmenopausal women.
How it is taken
Raloxifene 60 mg tablets are taken by mouth. The verified prescribing information states that the 60 mg tablet is taken once daily and may be taken at any time of day, with or without food. For osteoporosis, adequate calcium and vitamin D intake is important, and supplementation may be advised when dietary intake is insufficient. Follow the prescribed instructions rather than changing treatment or dosage independently.
Important warnings
Raloxifene increases the risk of venous thromboembolism, including deep-vein thrombosis and pulmonary embolism, and must not be used in women with an active or previous venous thromboembolism, including retinal vein thrombosis. Prolonged immobility further increases clot risk; prescribing information advises discontinuation at least 72 hours before and during prolonged immobilization, with treatment resumed only after the patient is fully mobile. Seek urgent medical attention for unexplained leg swelling or pain, sudden chest pain, shortness of breath, coughing up blood, or sudden visual changes. An increased risk of death due to stroke was observed in a study of postmenopausal women with coronary heart disease or increased coronary risk, so individual stroke risk requires consideration. Use requires caution with hepatic impairment and moderate or severe renal impairment. Concomitant cholestyramine or similar anion-exchange resins is not recommended; warfarin may require closer prothrombin-time monitoring when raloxifene is started or stopped. Concurrent systemic estrogen use is not recommended.
Side effects and monitoring
Common effects include hot flashes and leg cramps; clinical studies also reported effects such as peripheral edema, headache, nausea, joint pain, sweating, and flu-like symptoms. Serious risks include deep-vein thrombosis, pulmonary embolism and, rarely, retinal vein occlusion or stroke. Obtain urgent medical attention for one-sided leg swelling or pain, sudden chest pain, breathing difficulty, coughing up blood, or sudden changes in vision. Women using warfarin or related anticoagulants may need closer prothrombin-time monitoring when raloxifene is started or stopped.
Pregnancy
Raloxifene is contraindicated during pregnancy and is not indicated for women of reproductive potential. Its mechanism may interfere with estrogen functions that are important during pregnancy, and animal studies have shown fetal and developmental harm.
Breastfeeding
Raloxifene is not indicated for women of reproductive potential. It is not known whether raloxifene is present in human milk or what effects it may have on a breastfed infant or milk production. Based on its mechanism, it may interfere with estrogen functions in breast tissue during lactation.
Food, drink and interactions
No specific direct alcohol interaction is established in the verified prescribing information reviewed. For osteoporosis care, excessive alcohol consumption is a recognized behavioral factor that should be addressed.
Food and drink
Raloxifene may be taken with or without food. For osteoporosis prevention or treatment, adequate dietary calcium and vitamin D are important; supplementation may be advised if intake is inadequate.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Product-specific Estroact storage instructions were not independently verified.
Frequently asked questions
Will raloxifene actually improve my bone density?
Raloxifene reduces bone breakdown and can increase bone mineral density in postmenopausal women. It is approved for both prevention and treatment of postmenopausal osteoporosis.
Can raloxifene cause hot flashes or sweating?
Yes. Hot flashes are a recognized common effect of raloxifene and are particularly reported during the first months of treatment. Sweating has also been reported.
Should I worry about blood clots while taking raloxifene?
Blood clots are an important known risk. Raloxifene must not be used by women with a current or previous venous blood clot, and urgent medical attention is needed for symptoms such as unexplained leg swelling or pain, sudden chest pain, shortness of breath, or coughing up blood.
What should I do about raloxifene before surgery or a long period of bed rest?
Verified prescribing information advises stopping raloxifene at least 72 hours before and during prolonged immobilization because immobility increases blood-clot risk. Treatment should be resumed only after the patient is fully mobile, according to medical guidance.
Can I take raloxifene with food?
Yes. Raloxifene can be taken with or without food and at any time of day.
Do I need calcium and vitamin D while taking raloxifene for osteoporosis?
Adequate calcium and vitamin D intake is recommended for osteoporosis care. The prescribing information advises supplementation when dietary intake is inadequate; the appropriate intake should be discussed with a healthcare professional.
Does raloxifene treat breast cancer?
No. Raloxifene can reduce the risk of invasive breast cancer in certain postmenopausal women, but it is not approved to treat invasive breast cancer or prevent recurrence of an existing breast cancer.
Can Cheap Generic Med ship Estroact to the United States?
Cheap Generic Med serves the United States under its international shipping model. Delivery is typically estimated at 10–14 business days after dispatch, although customs or carrier delays can extend transit; prescription and import requirements may also apply.
Sources
Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.
Related products
Danogen 200 Mg (Danazol)
Danogen 50 Mg (Danazol)
Femalegra 100 Mg (Sildenafil)
Folvite MB Capsule (Folic Acid)
Lovegra 100 Mg (Sildenafil)
Oestrogel 2.5 gm/1.5 mg (Estradiol)
Reviews
There are no reviews yet.